An interventional study of ankel stirrup and Foot-ankel brace (walker) in Ankle Fracture, Rehabilitation and Recovery, sponsored by Odense University Hospital. Recruiting at 16 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-29.
Sponsored by Odense University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Ankle Fractures with a site in Denmark — 2 open to participants now, 2 under way, none of them phase 3. Ankle Fractures · Denmark.
Among the 11 studies in Ankle Fractures with a site in Denmark, this one is one of 2 that started in 2026, is one of 7 with no phase, and was the 10th registered.
203 studies on the registry are indexed under Ankle Fractures; 45 are open to participants now.
Browse Ankle Fractures studies →2 of the 11 studies in Ankle Fractures with a site in Denmark are open now. Recruiting first, the newest first:
Odense University Hospital · Sites in Denmark
Ages 18+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 31 Ankle Fractures studies recruiting now, 14 (45%) set no upper age limit and 12 (39%) stop at 75 or younger; 4 take children under 18; 3 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 1,400 is above the median of 90 across 151 interventional studies indexed under Ankle Fractures.
Median enrollment 156 across the 7 interventional studies, 43 across the 4 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 11 has an industry lead sponsor. The 10 most frequent:
Odense University Hospital is the lead sponsor of 480 studies on the registry; 111 are open to participants now.
Odense University Hospital has 2 studies filed under Ankle Fractures — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 11 studies in Ankle Fractures with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Ankle fractures are common, debilitating and usually treated with immobilisation using a foot-ankle brace (walker). Emerging evidence suggests that a less restrictive brace may reduce recovery time without increasing the risk of complications, and patients tend to prefer ankle stirrups. However, evidence supporting their non-inferiority remains limited and inconclusive. Thus, the aim is assess if an ankle stirrup is non-inferior to a standard walker in reducing pain and function measured by the Manchester-Oxford Foot Questionnaire (MOXFQ) three months after ankle fracture. The hypothesis is that ankel stirrups align better with patients preferenes for less immobilising braces and offer sufficient stability while the fracture heals. Secondarily it may lead to faster recovery of function, return to work and reduced cost. The sample size of a maximum of 1400 patients allow us to assess non-inferiority in age and sex specific subgroups and treatment (surgical or non-sugical). Non-inferiority will be assessed in a pragmatic, multicenter, randomised controlled trial involving Scandinavian orthopedic departments.
Ankle fractures are the third most occuring fracture. After an ankle fracture, patients experience reduced ankle function and pain [3]. Also, evidence with moderate to high risk of bias indicate that immobilisation prolong patients recovery. However, high quality evidence are necessary for finite conclusions.
In Scandinavia, foot-ankle braces (walkers) are used to immobilise the fracture while healing. Even though patients acknowledge the need for immobilisation, a qualitative study of ten patients found that patients experienced difficulties in adhering to the recommendation of immobilisation after ankle fracture. A randomised controlled trial (RCT) by Smeeing et al. 2020 found that braces and elastic bands that allow more ankle movement than walkers did not lead to poorer functional outcomes (p=0.56), but may lead to a faster return to work (p = 0.02) without increased complications (p=0.63). The RCT was terminated when half the sample had been included, thus questioning the statistical power of the findings. Based on patient interviews completed during trial preparations we learned that patients preferred ankle stirrups as they allowed movement during use. The same patients also expressed an aversion to the walker, while being hesitant that ankle-supporting elastic bandages provided sufficient support.
Compared to the walker, ankle stirrups may better align with patient preferences while remaining non-inferior in restoring ankle-related outcomes such as pain and function.
Patients will be included in the orthopedic outpatient departments and randomised to a walker or an ankle stirrup. Randomisation will be in blocks to ensure that surgically and non-surgically patients are evenly distributed between groups and that each center will have an equal amount of intervention and control patients. Weightbearing will be unrestricted in both groups so the difference will be the brace (ankel stirrup or walker). Other variation will be a reflection of usual practice. The primary outcome is a validated score including pain, function and social interaction 12 weeks after ankel fracture. The sample size is calculated to 140 patients per each of six subgroups (males 18-39, females 18-39, males 40-59, females 40-59, males 60+, females 60+) randomisation stop when the smallest subgroup (females 18-39 years) reaches 140 or a maximum of 1400 has been included. Patients have been involved in designing the trial and a former ankle fracture patient serves a member of the steering committee.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Walker: immobilisation during use
Other: Foot-ankel brace (walker)
Ankel stirrup: active ankel dorsal and plantar flextion during use
Other: ankel stirrup
Ankel stirrups are a patient preferred ankel brace that allow active ankle dorsal and plantar flexion during weightbearing while maintaining lateral stability.
Walkers immobilise and stabilise the ankle during weightbearing.
Index score (0-100) of the Manchester-Oxford Foot Questionnaire (MOXFQ)
The index score of the Manchester-Oxford Foot Questionnaire (MOXFQ) three months after randomisation is chosen as the primary outcome. Patients prefer MOXFQ, and it is a valid and reliable self-administered 16-item patient-reported outcome (PRO) divided into three dimensions (walking/standing seven items, pain five items and social interaction four items). MOXFQ will be summarised as an index score covering the most important dimensions patients indicated after ankle fracture (e.g. pain, function and social interaction). Response options consist of a 5-point Likert scale ranging from zero to four. The MOXFQ index score will be calculated by summing the raw scores of the 16 items of the MOXFQ to a index score ranging from a minimum of 0 to a maximum of 100, where 100 represents the most severe health state.
Time frame: Measured as the change from baseline and after 6 and 12 weeks
Physical activity
The short-form International Physical Activity Questionnaire (IPAQ-SF) measure physical activity in five domains, including work-related physical activity, transportation, housework, leisure time and time spent sitting. Patients will be grouped into low, moderate and high physical activity levels depending on activities and time spent doing these activities.
Time frame: Measured as the change from baseline and after 6 and 12 weeks
Health-related Quality Of Life (HRQOL)
HRQOL will be measured using the EuroQol five-dimension five-level questionnaire (ed-5d-5l)
Time frame: Measured as the change from baseline and after 6 and 12 weeks
Ankle dorsiflexion
is measured using the knee-to-wall test, which measures ankle mobility in degrees of motion in standing.
Time frame: Measured as the change from baseline and after 6 and 12 weeks
Ankle strength
is measured using the heel rise test. Patients perform as many single-leg heel raises at a cadence of one per second until fatigue or a maximum of 50 is reached. The test is performed on both legs, and normal function is recovered if the difference in heel raises between legs is 10% or less.
Time frame: Measured as the change from baseline and after 6 and 12 weeks
Hospital costs
Hospital Costs will be measured from a hospital perspective with a time horizon of three months and include cost of procedures and in-hospital activities.
Time frame: Measured as the total cost from baseline and after 12 weeks
Return to work
Will be measured by asking patients what date they returned to work (full-time and part-time). Information on work-related physical requirements (e.g., blue-collar or white-collar workers) and usual employment status (e.g., retiree, unemployed, working) will also be collected.
Time frame: From fracture and until date of return to work.
Index score (0-100) of the Manchester-Oxford Foot Questionnaire (MOXFQ) in subgroups
The index score of the Manchester-Oxford Foot Questionnaire (MOXFQ) three months after randomisation is chosen as the primary outcome. Patients prefer MOXFQ, and it is a valid and reliable self-administered 16-item patient-reported outcome (PRO) divided into three dimensions (walking/standing seven items, pain five items and social interaction four items). MOXFQ will be summarised as an index score covering the most important dimensions patients indicated after ankle fracture (e.g. pain, function and social interaction). Response options consist of a 5-point Likert scale ranging from zero to four. The MOXFQ index score will be calculated by summing the raw scores of the 16 items of the MOXFQ to a index score ranging from a minimum of 0 to a maximum of 100, where 100 represents the most severe health state and analysed in subgroups: males 18-39, females 18-39, males 40-59, females 40-59, males 60+, females 60+ and in treatment groups (surgical and non-surgical)
Time frame: Measured as the change from baseline after 6 and 12 weeks.
Adverse Events (AE) and Serious Adverse Events (SAE)
Adverse events are undesirable experiences that may occur during brace use as: i) skin irritation, blisters, or pressure sores due to poor fit, friction, or prolonged use, ii) swelling or increased edema, iii) pain or discomfort resulting from tightness, misalignment, or mechanical pressure, iv) delayed fracture healing due to excessive joint movement, v) Muscle atrophy or joint stiffness from immobilization, vi) reduced range of motion (ROM) and vii) removal of material (e.g., screws) due to discomfort or healing complications. Serious adverse events are complications requiring hospitalisation, surgical intervention, or posing a significant risk to the patient as i) death (e.g., an unexpected cardiac event occurring during the study period) ii) hospitalisation due to falls resulting from brace-related instability, iii) wound infection requiring inpatient treatment, potentially related to brace-induced i
Time frame: Safety reporting for each patient will begin at baseline and after 6 and twelve weeks
The index score of the Manchester-Oxford Foot Questionnaire (MOXFQ)
The index score of the Manchester-Oxford Foot Questionnaire (MOXFQ) three months after randomisation is chosen as the primary outcome. Patients prefer MOXFQ, and it is a valid and reliable self-administered 16-item patient-reported outcome (PRO) divided into three dimensions (walking/standing seven items, pain five items and social interaction four items). MOXFQ will be summarised as an index score covering the most important dimensions patients indicated after ankle fracture (e.g. pain, function and social interaction). Response options consist of a 5-point Likert scale ranging from zero to four. The MOXFQ index score will be calculated by summing the raw scores of the 16 items of the MOXFQ to a index score ranging from a minimum of 0 to a maximum of 100, where 100 represents the most severe health state.
Time frame: Change from baseline to 6 and 12 months follow-up
Physical activity long term
Physical activity will be measured in longer term using the short-form International Physical Activity Questionnaire (IPAQ-SF) and grouping patients into low, moderate and high physical activity levels.
Time frame: Change from baseline and after 6 and 12 months
Health-related Quality Of Life (HRQOL) long term
Long term Health-related Quality Of Life (HRQOL) will be measured using the EuroQol five-dimension five-level questionnaire (ed-5d-5l)
Time frame: Baseline and after 6 and 12 months
The index score of the Manchester-Oxford Foot Questionnaire (MOXFQ) in subgroups long term
The index score of the Manchester-Oxford Foot Questionnaire (MOXFQ) three months after randomisation is chosen as the primary outcome. Patients prefer MOXFQ, and it is a valid and reliable self-administered 16-item patient-reported outcome (PRO) divided into three dimensions (walking/standing seven items, pain five items and social interaction four items). MOXFQ will be summarised as an index score covering the most important dimensions patients indicated after ankle fracture (e.g. pain, function and social interaction). Response options consist of a 5-point Likert scale ranging from zero to four. The MOXFQ index score will be calculated by summing the raw scores of the 16 items of the MOXFQ to a index score ranging from a minimum of 0 to a maximum of 100, where 100 represents the most severe health state and analysed in subgroups: males 18-39, females 18-39, males 40-59, females 40-59, males 60+, females 60+ and in treatment groups (surgical and non-surgical)
Time frame: Change from baseline and after 6 and 12 months
Incremental cost per quality adjusted life year gain
cost-utility analysis will be completed alongside the clinical trial. Reporting will be from a societal perspective and with an one year timeframe. Utility will be measured in Quality Adjusted Life Years (QALY) by assigning values from the Danish eq-5d-5l reference set (i.e. each health state is assigned a value between -0.759 to 1.000 \[40\]. The follow-up period will be one year (t4). Costs will be collected from national registris. These, among others, include information on admissions, out-patient visits, home care services, contacts with general practitioners and other private healthcare professionals, prescription medication and welfare subsidies due to sick leave. Hours of informal care the last week patients receive from family and friends will be collected from patients at every follow-up (t1-t4). The reported amount will be assumed stable between time points. Valuation will based on the recommendations of the Health Technology Council and reported in euros (€) using the most
Time frame: one year from baseline
carbon footprint of the trial
Carbon footprint of the BAF trial will be estimated by registrering activities associated with design, management and operation of the trial and summing the carbon of to estimate the overall carbon footprint (kgCO2e) using the Clinical Trial Carbon Calculator. Registered activities will be: cradle to gate estimate of ankle stirrups and foot-ankle braces, patients visits to hospital, mean of transportation to visits (car, public or bike, trial staff travel and mean of transportation to recruitments centers.
Time frame: From baseline and after 6 and 12 weeks
Adverse Events and Serious Adverse Events (SAE) long term
Adverse events are undesirable experiences that may occur during brace use as: i) skin irritation, blisters, or pressure sores due to poor fit, friction, or prolonged use, ii) swelling or increased edema, iii) pain or discomfort resulting from tightness, misalignment, or mechanical pressure, iv) delayed fracture healing due to excessive joint movement, v) Muscle atrophy or joint stiffness from immobilization, vi) reduced range of motion (ROM) and vii) removal of material (e.g., screws) due to discomfort or healing complications. Serious adverse events are complications requiring hospitalisation, surgical intervention, or posing a significant risk to the patient as i) death (e.g., an unexpected cardiac event occurring during the study period) ii) hospitalisation due to falls resulting from brace-related instability, iii) wound infection requiring inpatient treatment, potentially
Time frame: Safety reporting for each patient will begin at baseline and after 6 and 12 months
Physical activity
A subgroup of patients will have their physical activity objectively evaluated using an accelerometer. The SENS Accelerometer is widely used and validated for young and older orthopedic patients. The accelerometer measures total accelerometer counts per day (a valid proxy for physical activity), rest time, standing time, active time (walking time, running, cycling), number of steps, movement intensity and sleep duration for four weeks. The total amount of accelerometer counts will be used to measure the level of physical activity between groups \[39\]. The accelerometer will be placed on the patients thigh at the day of randomization and followed for a minimum of 12 weeks.
Time frame: From baseline and for a minimum of 12 weeks
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), will be provided to anyone who wishes to access the data.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Immediately following publication, no end date.
Access criteria: Any researcher, affiliated to an established institution
Started Apr 2026 (actual). Primary completion is estimated for Sep 2028, 29 months after the start.
Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 29 months is below that.
Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.